Facilitating Innovative Nuclear Diagnostics Act of 2021
Official title: To amend title XVIII of the Social Security Act to ensure equitable payment for, and preserve Medicare beneficiary access to, diagnostic radiopharmaceuticals u… Show full official titleShow less
Official title: To amend title XVIII of the Social Security Act to ensure equitable payment for, and preserve Medicare beneficiary access to, diagnostic radiopharmaceuticals under the Medicare hospital outpatient prospective payment system.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Facilitating Innovative Nuclear Diagnostics Act of 2021
This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2022 and as adjusted based on a specified fee schedule factor in each year thereafter.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 4479: Facilitating Innovative Nuclear Diagnostics Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-4479/
"H.R. 4479: Facilitating Innovative Nuclear Diagnostics Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-4479/.
H.R. 4479, 117th Cong. (2026), https://openamerica.io/bill/117-HR-4479/.
[H.R. 4479: Facilitating Innovative Nuclear Diagnostics Act of 2021](https://openamerica.io/bill/117-HR-4479/)